All In Biotech

Drug Trial Radar · NCT05834738

Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA Nephropathy

A Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA Nephropathy on Sodium-glucose Cotransporter-2 Inhibitors (SGLT2i)

Last checked: Nov 20, 2026Latest source record: Jul 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

54

Actual

Start

Jul 20, 2023

Primary completion

Jun 30, 2025

Study completion Oct 29, 2025

Sponsor

Lead sponsor
Novartis PharmaceuticalsNovartis (NVS)
Sponsor type
Industry
First posted
Apr 28, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Crossover
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The ASSIST study was a phase 2, double-blind, placebo-controlled crossover study to evaluate the safety and efficacy of atrasentan vs. placebo in subjects with IgA nephropathy (IgAN) while on background standard of care therapy and an SGLT2 inhibitor (SGLT2i).

Conditions

  • IgA Nephropathy
  • Immunoglobulin A Nephropathy

Interventions

  • AtrasentanDrug

    Period A (12 Weeks) - Film-coated tablet, Washout Period: 12 weeks, Period B (24 Weeks) - Placebo

  • AtrasentanDrug

    Period B (12 Weeks) - Placebo, Washout Period: 12 weeks, Period A (24 Weeks) - Film-coated tablet

  • PlaceboDrug

    Placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage Change in Proteinuria (UPCR From a 24-Hour Urine Collection) From Baseline to Week 12Time frame: From Baseline to Week 12

Locations

30 sites in 6 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham (UAB) - The Kirklin Clinic (TKC) - Nephrology Clinic

    Birmingham, Alabama

  • Fides Clinical Research

    Atlanta, Georgia

  • NANI Research

    Oak Brook, Illinois

  • Tufts Medical Center

    Boston, Massachusetts

  • University of North Carolina at Chapel Hill - Nephrology and Hypertension

    Chapel Hill, North Carolina

  • University of Pennsylvania

    Philadelphia, Pennsylvania

  • The St. George Hospital

    Kogarah, New South Wales, Australia

  • Prince of Wales Hospital

    Sydney, New South Wales, Australia

  • Monash Health- Monash Medical Centre

    Melbourne, Victoria, Australia

  • Sunshine Hospital

    St Albans, Victoria, Australia

  • NUPEC Cardio

    Belo Horizonte, Minas Gerais, Brazil

  • Santa Casa de Misericordia de Porto Alegre

    Porto Alegre, Rio Grande do Sul, Brazil

  • Universidade Federal de Sao Paulo

    São Paulo, São Paulo, Brazil

  • Hospital das Clinicas da Faculdade de Medicina da USP

    São Paulo, São Paulo, Brazil

  • Hopsital Sultanah Aminah Johor Bharu (HSAJB) - Bangunan Bakawali Heodialysis Centre

    Johor Bahru, Johor Darul Takzim, Malaysia

  • Universiti Kebangsaan Malaysia (UKM) - Medical Centre (Pusat Perubatan) (Hospital Canselor Tuanku Muhriz (HCTM))

    Cheras, Kuala Lumpur, Malaysia

  • University Malaya Medical Centre

    Kuala Lumpur, Kuala Lumpur, Malaysia

  • Hospital Raja Permaisuri Bainun (HRPB)

    Ipoh, Perak, Malaysia

  • Dong-A University Medical Center (Dong-A University Hospital)

    Busan, Busan, South Korea

  • Soon Chun Hyang Central Medical Center (SCHMC) - Soon Chun Hyang University Hospital

    Cheonan, Chungnam-Do, South Korea

  • Hallym University Sacred Heart Hospital

    Anyang-si, Gyeonggi-do, South Korea

  • Chung-Ang University College

    Seoul, Seoul, South Korea

  • Hospital Torrecardenas

    Almería, Spain

  • Hospital del Mar

    Barcelona, Spain

  • Hospital del Vall d´Hebron

    Barcelona, Spain

  • Hospital Ribera Polusa

    Lugo, Spain

  • Hospital Universitario De Getafe (HUG)

    Madrid, Spain

  • Hospital 12 de Octubre

    Madrid, Spain

  • Hospital Virgen Macarena

    Seville, Spain

  • Hospital Clinico Universitario

    Valencia, Spain

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.